Document is current
Any future updates will be listed below
-
Authors
Weber, Christopher M.
Hafner, Antonina
Kirkland, Jacob G. https://orcid.org/0000-0001-5617-7065
Braun, Simon M. G. https://orcid.org/0000-0003-2622-9914
Stanton, Benjamin Z. https://orcid.org/0000-0002-2613-2955
Boettiger, Alistair N.
Crabtree, Gerald R. https://orcid.org/0000-0001-9685-7911
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute
Foundation for the National Institutes of Health (R01CA163915)
Foundation for the National Institutes of Health (R37NS046789)
Foundation for the National Institutes of Health (DP2GM132935)
- License Information
-
More Information
Article History
Received: 7 December 2020
Accepted: 10 May 2021
First Online: 11 June 2021
Competing interests
: G.R.C. is founder and stockholder of Foghorn Therapeutics. The other authors declare no competing interests.
